4.5 Article

Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date

Lanfranco Pellesi et al.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)

Review Clinical Neurology

Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine

Peer Tfelt-Hansen et al.

CNS DRUGS (2017)

Article Clinical Neurology

Targeting CGRP: A New Era for Migraine Treatment

Stephanie Wrobel Goldberg et al.

CNS DRUGS (2015)

Article Multidisciplinary Sciences

A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache

Jeffrey L. Jackson et al.

PLOS ONE (2015)

Article Neurosciences

Latin American consensus on guidelines for chronic migraine treatment

Alex Rodrigo Espinoza Giacomozzi et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2013)

Review Clinical Neurology

Psychiatric comorbidities of episodic and chronic migraine

Dawn C. Buse et al.

JOURNAL OF NEUROLOGY (2013)

Article Clinical Neurology

Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders

Abouch Valenty Krymchantowski et al.

JOURNAL OF HEADACHE AND PAIN (2012)

Article Clinical Neurology

Polytherapy for migraine prophylaxis

G. Casucci et al.

NEUROLOGICAL SCIENCES (2012)

Article Clinical Neurology

Polytherapy for the prophylaxis of chronic migraine: an Italian survey

D. D'Amico et al.

NEUROLOGICAL SCIENCES (2011)

Review Clinical Neurology

Pathophysiology of Migraine

Peter J. Goadsby

NEUROLOGIC CLINICS (2009)

Review Clinical Neurology

Migraine-associated risks and comorbidity

H. C. Diener et al.

JOURNAL OF NEUROLOGY (2008)

Article Clinical Neurology

Migraine prevalence, disease burden, and the need for preventive therapy

R. B. Lipton et al.

NEUROLOGY (2007)